Bioenergetic Effect of Pioglitazone in CLD-PH

Conditions: Pulmonary Hypertension; Pulmonary Hypertension (PH) Due to Chronic Lung Disease Interventions: Drug: Pioglitazone 30mg; Drug: Placebo; Diagnostic Test: Labs Sponsors: Emory University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials